Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HTLV Blot 2.4 Post-Market Clinical Study of Neurological Disorders and HTLV Positive Specimens

NCT03226119 is registered in ClinicalTrials.gov with MP Biomedicals, LLC as lead sponsor.

NCT NCT03226119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03226119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HTLV Blot 2.4 Post-Market Clinical Study of Neurological Disorders and HTLV Positive Specimens
Lead sponsor
MP Biomedicals, LLC
Phase
Phase 4
Overall status
Completed
Start date
January 15, 2018
Completion date
August 31, 2018
Enrollment
150 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

htlv i associated myelopathies, htlv i associated t cell leukemia lymphoma, htlv-i infections, htlv-ii infections, human t-lymphotropic virus 1, human t-lymphotropic virus 2